Wegovy Singapore: Availability, Cost, Eligibility & Safety

Medically reviewed by Dr. Bosty Chan – MBChB (UK), MRCS (Edinburgh), Cert. in Andrology (Men’s Health)
Key Information
Wegovy contains semaglutide, a prescription medicine used for chronic weight management in eligible patients. It is prescribed alongside dietary changes, physical activity and ongoing medical review.
This guide explains Wegovy’s availability in Singapore, eligibility, dosing, clinical evidence, side effects, cost considerations and prescription requirements.
Go to FAQ

Wegovy in Singapore: Key Information
- Availability: Wegovy is available in Singapore as a prescription-only medicine. Supply of individual strengths may vary.
- Active ingredient: Semaglutide, a GLP-1 receptor agonist.
- Purpose: Chronic weight management in eligible patients alongside lifestyle measures.
- Eligibility: Generally, adults with a BMI of 30 kg/m² or above, or 27 kg/m² or above with a weight-related condition, subject to the approved product information and clinical assessment.
- Administration: Usually a once-weekly injection, with gradual dose escalation.
- Prescription: A medical assessment and valid prescription are required.
- Cost: Varies according to dose, quantity supplied and provider. Consultation and other charges may be separate.
- Safety: Side effects and contraindications should be reviewed with a healthcare professional before treatment.
What is Wegovy and How Does It Work?
Wegovy contains semaglutide, which acts on glucagon-like peptide-1 (GLP-1) receptors involved in appetite regulation and blood glucose control.
It can help reduce hunger and increase feelings of fullness, supporting weight management alongside dietary changes and physical activity.
Semaglutide is also used in other prescription medicines, but the products differ in approved indications, dosing and administration.
For an explanation of the active ingredient and its different formulations, read our Semaglutide Singapore guide.
Is Wegovy the Same as Ozempic?
No. Wegovy and Ozempic both contain semaglutide, but they have different approved indications and dosing instructions.
Wegovy is used for weight management in eligible patients, while Ozempic is approved in Singapore for specified uses in type 2 diabetes.
Read our Ozempic Singapore guide for more information about its approved uses, availability and safety.
Wegovy Availability and Prescription Requirements in Singapore
Wegovy is available in Singapore as a prescription-only medicine. A doctor must assess whether it is suitable based on medical history, current medicines, weight-related conditions and other clinical considerations.
Availability of individual strengths and presentations may vary. Patients should confirm current supply with an appropriately licensed healthcare provider.
Where Can Patients Obtain Wegovy in Singapore?
Prescription medicines should be obtained through lawful healthcare and dispensing channels.
Patients should avoid unverified websites, social media sellers and unauthorised sources. These may present risks involving counterfeit medicines, improper storage or unsuitable treatment.
For further information about prescription-medicine safety and regulation, see the Health Sciences Authority (HSA).
Can Wegovy Be Prescribed Through Telemedicine?
Some medical assessments and follow-up consultations may take place through licensed telemedicine services where clinically appropriate.
However, an online consultation does not guarantee a prescription. A doctor must determine whether treatment is suitable and whether an in-person examination or further assessment is needed.
Medicine supply must follow Singapore’s applicable prescribing and dispensing requirements.
Who May Be Suitable for Wegovy?
Wegovy may be considered for eligible adults who meet the approved weight management criteria.
Common adult BMI thresholds include:
- BMI of 30 kg/m² or above: Obesity.
- BMI of 27 kg/m² or above: Overweight with at least one weight-related condition, such as hypertension, dyslipidaemia or type 2 diabetes.
BMI alone does not determine whether treatment is appropriate. A doctor will consider the patient’s medical history, existing conditions, current medicines and overall health.
When Might Wegovy Not Be Suitable?
Wegovy is not suitable for everyone.
Patients should inform their doctor about pregnancy or pregnancy plans, breastfeeding, allergies, a history of pancreatitis or gallbladder disease, significant gastrointestinal symptoms, and other relevant medical conditions.
Patients using medicines for diabetes should also discuss the possibility of low blood glucose when treatments are combined.
The current Singapore-approved product information should be used to confirm contraindications, warnings and precautions.
Wegovy Dosage and Administration
Wegovy is generally given as a once-weekly subcutaneous injection.
Treatment typically starts at a lower dose and increases gradually to improve tolerability.
|
Treatment Period |
Common Weekly Dose |
|---|---|
|
Weeks 1-4 |
0.25 mg |
|
Weeks 5-8 |
0.5 mg |
|
Weeks 9-12 |
1.0 mg |
|
Weeks 13-16 |
1.7 mg |
|
Week 17 onwards |
2.4 mg, where appropriate |
The schedule should be verified against the current Singapore-approved product information. Dose escalation may need to be delayed or adjusted based on tolerability and clinical assessment.
Patients should not independently change their dose.
How is Wegovy Injected?
Wegovy is injected under the skin, usually in the abdomen, thigh or upper arm, according to the instructions for the supplied pen.
Patients should receive training from a healthcare professional and follow the manufacturer’s instructions for use, including storage, injection technique and disposal.
Pen presentations may differ between markets, so instructions should match the product supplied in Singapore.
For a discussion of research involving higher-dose semaglutide, see our Wegovy 7.2 mg Singapore article. Investigational or overseas dosing developments should not be confused with locally approved dosing.
How Effective is Wegovy for Weight Management?
Clinical trials have evaluated semaglutide 2.4 mg alongside dietary and physical activity interventions.
How Much Weight Loss was Observed in Clinical Trials?
In the STEP 1 trial, adults with overweight or obesity who did not have diabetes received once-weekly semaglutide 2.4 mg or placebo, alongside lifestyle interventions.
After 68 weeks, participants receiving semaglutide experienced an average body weight reduction of 14.9%, compared with 2.4% in the placebo group.
These are trial averages rather than guaranteed individual outcomes. Treatment response varies, and some patients may not tolerate or benefit from treatment.
Read the original study: Wilding et al., New England Journal of Medicine (2021).
What Other Health Outcomes Have Been Studied?
Semaglutide has also been studied for changes in waist circumference, blood pressure, blood glucose measures and other cardiometabolic outcomes.
Some studies have evaluated cardiovascular outcomes in selected patient populations. These results should be interpreted in the context of the study population and the specific product and indication being investigated.
Wegovy vs Other Weight Management Medicines
Different prescription medicines have different mechanisms, indications, dosing schedules and safety considerations.
|
Medicine |
Active Ingredient |
General Mechanism |
|---|---|---|
|
Wegovy |
Semaglutide |
GLP-1 receptor agonist |
|
Mounjaro |
Tirzepatide |
GIP and GLP-1 receptor agonist |
|
Saxenda |
Liraglutide |
GLP-1 receptor agonist |
|
Orlistat |
Orlistat |
Reduces absorption of some dietary fat |
These medicines are not interchangeable. The appropriate treatment, if any, depends on individual clinical circumstances.
For information about tirzepatide, read our Mounjaro Singapore guide.
For an educational comparison involving other prescription weight management medicines, see Wegovy vs Panbesy vs Duromine.
Wegovy Side Effects and Safety Considerations
Commonly reported side effects of Wegovy include nausea, vomiting, diarrhoea, constipation and abdominal discomfort.
Symptoms may occur when treatment begins or the dose increases. Some improve over time, but persistent or severe symptoms should be assessed by a healthcare professional.
More serious risks and precautions include pancreatitis, gallbladder disease, dehydration and low blood glucose when used with certain diabetes medicines.
Seek prompt medical attention for severe or persistent abdominal pain, significant vomiting, symptoms of dehydration or signs of a serious allergic reaction.
Patients should also inform healthcare professionals about semaglutide use before procedures involving anaesthesia or deep sedation.
Wegovy and Type 2 Diabetes
Semaglutide affects blood glucose regulation, but the approved weight management indication for Wegovy should be distinguished from the approved uses of other semaglutide products.
Patients with type 2 diabetes may need additional monitoring, particularly if they use insulin or sulfonylureas.
How Long is Wegovy Treatment Usually Needed?
Weight management often requires long-term support.
Treatment duration depends on clinical response, tolerability, medical circumstances and ongoing review.
Weight regain may occur after semaglutide is stopped. Long-term dietary habits, physical activity and behavioural support remain important.
A clinical trial examining continued semaglutide treatment and withdrawal is available here: Rubino et al., JAMA (2021).
Wegovy Price and Cost in Singapore
Wegovy prices in Singapore vary according to dose, quantity supplied, healthcare provider and any additional services.
When comparing costs, patients should distinguish between:
- Medication-only cost: The amount charged for the prescribed medicine over a defined supply period.
- Consultation fees: Charges for medical assessment or follow-up.
- Other charges: Tests, monitoring, delivery or other services where applicable.
The prescribed dose and supply duration are important when comparing prices. A quotation for one pen, four weeks of treatment or a calendar month may not represent the same quantity of medicine.
Patients should confirm current prices, inclusions and supply duration with the relevant provider.
For a more detailed explanation, read our Wegovy Singapore price guide.
Is Wegovy Covered by Insurance in Singapore?
Coverage depends on the insurer, policy and treatment indication. Patients should check whether medicine, consultation and monitoring charges are covered separately.
Medical Assessment and Follow-Up in Singapore
Patients considering prescription weight management treatment should undergo an appropriate medical assessment.
A doctor may review medical history, existing health conditions, current medicines, previous weight management efforts and treatment goals.
Where clinically appropriate, consultations and follow-up may be conducted through licensed telemedicine services. Some patients may need an in-person examination or further investigations.
Ongoing reviews help assess treatment response, side effects and whether the management plan remains appropriate.
Frequently Asked Questions About Wegovy in Singapore
Still have questions?
References and Further Reading
- Health Sciences Authority (Singapore) — medicine regulation and safety information.
- HealthHub Singapore — patient medicine information.
- Wilding et al., STEP 1 trial, NEJM (2021) — semaglutide 2.4 mg and weight management outcomes.
- Rubino et al., JAMA (2021) — continued semaglutide treatment and weight loss maintenance.
Sire’s Easy Telemedicine Process
Discreet consults and doorstep delivery. We’ve made men’s healthcare as simple as it should be.

Survey
Complete a quick online health questionnaire and connect with our licensed Singapore doctor via a secure video consultation.

Consult
Our doctor reviews your health profile and, if appropriate, prescribes a clinically-proven treatment plan tailored to your needs.

Delivery & Follow-Up
Your medication is shipped in discreet packaging with same-day delivery or self-collection. Our care team is here to support you.
Powered by Cloud Clinic
Sire is operated by Cloud Clinic, a healthcare institution licensed by the Ministry of Health (MOH), Singapore.
Learn more about LICENSING TELEMEDICINE SERVICE UNDER HCSA
Cloud Clinic is a Singapore healthcare institution focused on providing direct-to-home healthcare solutions. Every product and service we provide is supervised by our medical team.















